HP530
/ Hinova Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 10, 2023
Hinova Pharma Gets Regulatory Nod for Anti-Tumor Drug Trial
(Market Screener)
- "Hinova Pharmaceuticals...will hold clinical trials for its HP530S tablets for solid tumors after receiving approval from China's National Medical Products Administration."
New trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1